Cirugía y Especialidades Médico-Quirúrgicas
Departamento
![Foto de Cirugía y Especialidades Médico-Quirúrgicas](/img/noimage.png)
![Foto de Instituto Valenciano de Oncologia](/img/noimage_org.png)
Instituto Valenciano de Oncologia
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Instituto Valenciano de Oncologia (21)
2021
-
Current treatments for BCG failure in non-muscle invasive bladder cancer (NMIBC)
Actas Urologicas Espanolas, Vol. 45, Núm. 2, pp. 93-102
-
Head and neck cancer in times of COVID-19: Emotion-based medicine
Acta Otorrinolaringologica Espanola
2020
-
Consensus Document of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC), the Spanish Society of Otorhinolaryngology and Head and Neck Surgery (SEORL-CCC) and the Spanish Society of Anesthesiology and Resuscitation (SEDAR) on Tracheotomy in Patients with COVID-19 Infection
Revista Espanola de Anestesiologia y Reanimacion, Vol. 67, Núm. 9, pp. 504-510
-
Consensus document of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC), the Spanish Society of Otorhinolaryngology and Head and Neck Surgery (SEORL-CCC) and the Spanish Society of Anesthesiology and Resuscitation (SEDAR) on tracheotomy in patients with COVID-19 infection
Acta Otorrinolaringologica Espanola, Vol. 71, Núm. 6, pp. 386-392
-
Consensus document of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC), the Spanish Society of Otorhinolaryngology and Head and Neck Surgery (SEORL-CCC) and the Spanish Society of Anesthesiology and Resuscitation (SEDAR) on tracheotomy in patients with COVID-19 infection
Medicina Intensiva, Vol. 44, Núm. 8, pp. 493-499
-
Prognostic factors in patients with vulvar cancer: The VULCAN study
International Journal of Gynecological Cancer, Vol. 30, Núm. 9, pp. 1285-1291
-
Recommendations of the Spanish Society of Otolaryngology and Head and Neck Surgery for performing tracheotomies in patients infected by the coronavirus, Covid-19
Acta Otorrinolaringologica Espanola, Vol. 71, Núm. 4, pp. 253-255
2019
-
Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance
Prostate Cancer and Prostatic Diseases, Vol. 22, Núm. 1, pp. 84-90
2017
-
Erratum to: “Study protocol and pathology report standardization of intermediate potential and malignant soft tissue tumours in adolescents and adults” [Rev Esp Patol 50 (2) (2017) 100–112](S1699885517300016)(10.1016/j.patol.2016.12.003)
Revista Espanola de Patologia
-
Lymphovascular space invasion for endometrial cancer: Undertreatment and overtreatment risks: A survey of the Spanish gynecologic oncology group
International Journal of Gynecological Cancer, Vol. 27, Núm. 6, pp. 1191-1199
-
Protocol for the study of bone tumours and standardization of pathology reports
Revista Espanola de Patologia
-
Protocolo de estudio y estandarización del informe patológico de los tumores de partes blandas malignos y de comportamiento intermedio de adolescentes y adultos
Revista Espanola de Patologia
-
The management of active surveillance in prostate cancer: Validation of the Canary Prostate Active Surveillance Study risk calculator with the Spanish Urological Association Registry
Oncotarget, Vol. 8, Núm. 65, pp. 108451-108462
2016
-
Prognostic factors of recurrence and survival in vulvar melanoma
International Journal of Gynecological Cancer, Vol. 26, Núm. 7, pp. 1307-1312
2015
-
Sequential combination of mitomycin C plus bacillus calmette-guérin (BCG) is more effective but more toxic than BCG alone in patients with non-muscle-invasive bladder cancer in intermediate- and high-risk patients: Final outcome of CUETO 93009, a randomized prospective trial
European Urology, Vol. 67, Núm. 3, pp. 508-516
-
Spanish consensus on premature menopause
Maturitas, Vol. 80, Núm. 2, pp. 220-225
2014
-
Multicenter study of outcome in relation to the type of resection in rectal cancer
Diseases of the Colon and Rectum, Vol. 57, Núm. 7, pp. 811-822
2013
-
Tratamiento del tumor vesical no músculo infiltrante frente al problema de disponibilidad de bacilo de Calmette-Guerin. Consenso de un panel de expertos españoles
Actas Urologicas Espanolas, Vol. 37, Núm. 7, pp. 387-394
2009
-
Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model
Journal of Urology, Vol. 182, Núm. 5, pp. 2195-2203
2007
-
A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mitomycin C
European Urology, Vol. 52, Núm. 5, pp. 1398-1406